GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $54,012,000 | -3.3% | 467,997 | -18.4% | 0.06% | -16.7% |
| Q3 2020 | $55,854,000 | -20.6% | 573,752 | +0.1% | 0.07% | -24.2% |
| Q2 2020 | $70,341,000 | -38.8% | 573,180 | -56.3% | 0.10% | -2.1% |
| Q1 2020 | $114,888,000 | +13.0% | 1,311,948 | +34.9% | 0.10% | -21.1% |
| Q4 2019 | $101,673,000 | -7.4% | 972,387 | +1.9% | 0.12% | -12.8% |
| Q3 2019 | $109,794,000 | -14.7% | 954,484 | +27.8% | 0.14% | -45.8% |
| Q2 2019 | $128,778,000 | +86.8% | 747,015 | +82.7% | 0.26% | +65.6% |
| Q1 2019 | $68,935,000 | +212.2% | 408,940 | +80.4% | 0.16% | +185.5% |
| Q4 2018 | $22,081,000 | -52.0% | 226,730 | -14.8% | 0.06% | -42.1% |
| Q3 2018 | $45,987,000 | +7.5% | 266,220 | -13.1% | 0.10% | +4.4% |
| Q2 2018 | $42,770,000 | +27.0% | 306,510 | +2.5% | 0.09% | +24.7% |
| Q1 2018 | $33,686,000 | -2.4% | 298,975 | +14.4% | 0.07% | 0.0% |
| Q4 2017 | $34,506,000 | +38.6% | 261,390 | +6.5% | 0.07% | +30.4% |
| Q3 2017 | $24,905,000 | -19.6% | 245,395 | -20.6% | 0.06% | -22.2% |
| Q2 2017 | $30,971,000 | -9.5% | 308,945 | +9.2% | 0.07% | -11.1% |
| Q1 2017 | $34,229,000 | +19.5% | 283,025 | +10.4% | 0.08% | +12.5% |
| Q4 2016 | $28,652,000 | -5.0% | 256,387 | +12.8% | 0.07% | -14.3% |
| Q3 2016 | $30,161,000 | – | 227,237 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|